| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Richard A. Heyman is Director at ORIC and has filed Form 4s across 3 companies. From April 2020 to October 2026, the filings on record show 0 open-market purchases and 32 sales. Richard A. Heyman's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $3.3M at current prices.
Historically, Richard A. Heyman's trades have earned a strong insider score of 73/100 across 42 rated trades. Over a 12-month horizon, 77.1% of those trades were profitable, with an average 12-month return of +35.1%.
The biggest single holding is ORIC (~$2.3M) as Director. The ORIC filings lean toward selling, a net 38,028 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 30, 2024 | ELVN Enliven Therapeutics, Inc. | Director | Sell10b5-1 | 1,270 | $16.41 | $20,839.56 | -0.9% | +9.3% | +28.1% | |
| Dec 22, 2023 | ELVN Enliven Therapeutics, Inc. | Director | Sell10b5-1 | 216 | $13.00 | $2,808.00 | -0.7% | +21.6% | +51.3% | |
| Dec 20, 2023 | ELVN Enliven Therapeutics, Inc. | Director | Sell10b5-1 | 4,280 | $13.02 | $55,727.05 | -12.8% | +43.9% | +87.6% | |
| Sep 15, 2021 | ORIC Oric Pharmaceuticals, Inc. | Director | Sell | 1,388 | $25.04 | $34,759.74 | -0.6% | -52.1% | -86.6% | |
| Sep 13, 2021 | ORIC Oric Pharmaceuticals, Inc. | Director | Sell | 1,080 | $25.05 | $27,056.13 | -0.5% | -47.5% | -86.1% | |
| Sep 7, 2021 | ORIC Oric Pharmaceuticals, Inc. | Director | Sell | 1,086 | $25.11 | $27,272.18 | -0.5% | -41.9% | -86.2% | |
| Jun 1, 2021 | PMVP Pmv Pharmaceuticals, Inc. | Director | Sale+OE | 3,900 | $32.55 | $126,935.47 | - | -4.8% | -62.7% | |
| May 24, 2021 | ORIC Oric Pharmaceuticals, Inc. | Director | Sell | 1,400 | $25.15 | $35,208.03 | -0.6% | -9.8% | -86.1% | |
| May 18, 2021 | ORIC Oric Pharmaceuticals, Inc. | Director | Sell | 5,874 | $25.29 | $148,581.51 | -2.6% | -23.9% | -85.2% | |
| May 11, 2021 | ORIC Oric Pharmaceuticals, Inc. | Director | Sell | 100 | $25.11 | $2,511.00 | - | -33.9% | -89.0% |